Sep 5
Posted by Sabina Bhate in Principle-Based Ethics, The Pharmaceutical Industry, Whistleblowing | Comments off
KevinMD.com- 26 August, 2010
Author: Daniel J. Carlat
“Big Pharma was once a proud industry, a scientific crucible that created the first antibiotics, cardiac medications, and chemotherapeutics. But over the last fifteen years, the output of drug companies has gone into a steady decline. It is unclear exactly why the pipeline began to dry up, but in response, companies changed their business strategies.”
Read article here.
Aug 30
Posted by Sabina Bhate in Health Law, The Pharmaceutical Industry, Whistleblowing | Comments off
KevinMD.com-28 August, 2010
Author: Daniel Carlat
“… He was arguing that drug companies should be allowed to wine and dine doctors in order to sell them on their newest drugs. From his perspective, doctors, with all their training, should be smart enough to separate the hype from the truth. But unfortunately our extensive training does nothing to immunize us from the effects of marketing, as many companies have discovered.”
Read article here.
Aug 30
Posted by Sabina Bhate in Health Services, Medical Boards and Associations, Principle-Based Ethics, Whistleblowing | Comments off
Australian-28 August, 2010
Author: Mark Schliebs
“AMA president Andrew Pesce says optometrists working for optical retailers face a potential conflict of interest. Dr Pesce says this is due to the corporate emphasis on selling prescription glasses.Echoing the sentiments of some independent optometrists, Dr Pesce said those working for a retail company in a sector worth $1.2 billion posed some ethical questions.”
Read article here.
Aug 26
Posted by Nancy Lentz in Case Law, Safety, Whistleblowing | Comments off
Google News, AP, 26 August 2010
“A Canadian man was sentenced Wednesday to nearly three years in federal prison for selling fake cancer drugs over the Internet. Federal prosecutors in Phoenix say 22-year-old Hazim Gaber, of Edmonton, Alberta, was given a 33-month prison term and ordered to pay a $75,000 fine and nearly $54,000 in restitution. Gaber pleaded guilty to five counts of wire fraud in May. He was indicted in June 2009, arrested a month later in Germany and extradited to the U.S.”
Find article here.
Aug 24
Posted by Sabina Bhate in Product Liability, Regulatory Compliance, Safety, Whistleblowing | Comments off
Guardian- 20 August, 2010
Author: Mark King
“Illegal and potentially harmful tooth-whitening products are still being sold online despite websites agreeing to remove them from sale more than a fortnight ago following warnings from Which? Amazon and eBay agreed to remove the products, which experts say can burn the gums and leave brown stains on the teeth, after reviewing evidence from the consumer organisation.”
Read article here.
Aug 23
Posted by Sabina Bhate in Product Liability, Regulatory Compliance, The Pharmaceutical Industry, Whistleblowing | Comments off
KevinMD.com-18 August, 2010
Author: Michael Kirsch
“The Food and Drug Administration (FDA) wants physicians to turn in Big Pharma marketing and promotional materials that are misleading, that are poisoning us with information that reaches beyond FDA’s approved indications and regulations.”
Read article here.
Aug 18
Posted by Sabina Bhate in National Health Services, Resource Allocation, Vaccination, Whistleblowing | Comments off
Australian Doctor- 16 August, 2010
Author: Sarah Colyer
“A SCATHING review of this season’s child flu vaccine fiasco has highlighted the need for an urgent overhaul of Australia’s fragmented vaccine surveillance systems and closer co-operation between the states and the Commonwealth.”
Read article here.
Aug 17
Posted by Sabina Bhate in Clinical Ethics, National Health Services, Privacy & Health Information, Whistleblowing | Comments off
SMH- 17 August, 2010
“FOR seven years, former eastern suburbs doctor Lynette Bellamy quietly battled the Medicare watchdog over allegations of inappropriate practice, including poor medical record-keeping. Meanwhile, she rose through the Health Department ranks to an executive role overseeing initiatives to improve patient care in hospitals.”
Read article here.
Aug 16
Posted by Sabina Bhate in Clinical Ethics, Principle-Based Ethics, The Pharmaceutical Industry, Whistleblowing | Comments off
New York Times- 13 August, 2010
Authors: Gardiner Harris and Natasha Singer
“At least a dozen major drug and device makers are under investigation by federal prosecutors and securities regulators in a broadening bribery inquiry into whether the companies made illegal payments to doctors and health officials in foreign countries.”
Read article here.
Aug 14
Posted by Nancy Lentz in Death, End-of-life Decisions, Whistleblowing | Comments off
The Gisborne Herald, By Jeremy Muir, 14 August 2010
“Chief coroner Neil MacLean has called time on this secrecy. He wants restrictions on the reporting of suicides eased, and to encourage more openness, public debate and media coverage of New Zealand’s high suicide rate. More than 500 New Zealanders take their own lives each year, many more than die on our roads. Tragically, suicide is another “social indicator” where Tairawhiti is at the wrong end. Rates for some East Coast communities and Mahia would be among the worst in the world. From 2002-2006, the national suicide death rate was 12.2 per 100,000 people per year. In Gisborne/Hawke’s Bay it was 15.8 per 100,000 people. Among males here it was 24.3 per 100,000 people, compared to 18.5 nationwide. (Females, 7.7 per 100,000 here, 6.3 nationally.)”
Find article here.
You are currently browsing the archives for the Whistleblowing category.
Fill out the form below to signup to our email newsletter and we'll drop you a line once a week when new articles come up.
Arclite theme by digitalnature | Website by Tom Abbott | Powered by WordPress